Olipa karmaiseva tulos. Yhtä sopparia lisäksi “lykättiin” eikä tarkempaa tietoa annettu. Onneksi tämän miinan vältin, kun juuri alku viikosta katselin pitäisikö tämä ottaa taas salkkuun. Kerrankin näin 
April–June 2024 in summary
- Net revenue MSEK 114.7 (134.9), currency-adjusted net revenue amounted to MSEK 120.9
- Recurring revenue MSEK 74.1 (77.5)
- EBITDA MSEK 9.8 (29.7)
- EBITDA margin 8.5% (22.0%)
- Operating profit (EBIT) MSEK 1.6 (21.1)
- Operating margin 1.4% (15.6%)
- Earnings per share SEK -0.04 (1.18)
- Cash flow from current operations MSEK 19.1 (18.9)
“The second quarter was weaker compared to the same quarter last year. Japan, our largest market, has a lower base of renewable contracts in 2024 compared to 2023. In combination with the weakness of the Japanese yen, the revenues are negatively impacted by approximately MSEK 16. This, in combination with higher service costs in Germany have negatively affected the operating profit by approximately MSEK 14 in the quarter. Our other markets have not been able to mitigate or compensate for this deviation. The quarter has been eventful. We announced our largest deal to date in Cleanrooms, as well as additional contracts to the space industry in Cleanzones”, CEO Sebastian Lindström notes.
“In May 2024, QleanAir announced a cleanroom agreement with Curexa Pharmacy, with an order value of USD 2 500 000, which was planned for completion during 2024. QleanAir has today recived information from Curexa Pharmacy that they postpone the project. At this time, QleanAir do not know what this means in time or possible extent. QleanAir sees a risk that the project will not be completed in 2024 and is working on getting a clear picture of the situation and to understand the consequences.”